An increase of B cells in the tumor-bearing state has the potential to induce anti-tumor immunity

Immunobiology

Volumn 195, Issue 1, 1996, Pages 1-15

  Ito, Osamu ^a   Harada, Mamoru ^a   Takenoyama, Mitsuhiro ^a   Sumichika, Hiroshi ^a   Matsuzaki, Goro ^a   Nomoto, Kikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUMOR GROWTH;

EID: 0030020644     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80002-7     Document Type: Article

References (33)

1. BINZ, H., B. MEIER, and H. WIGZELL. 1982. Induction or elimination of tumor-specific immunity against a chemically-induced rat tumor using auto-anti-idiotypic immunity. Int. J. Cancer 29: 417.
2. FORSTROM, J. W., K. A. NELSON, G. T. NEPOM, I. HELLSTROM, and K. E. HELLSTRÖM. 1983. Immunization to a syngeneic sarcoma by a monoclonal auto-antiidiotypic antibody. Nature 303:627.
3. SETO, M., T. TAKAHASHI, S. NAKAMURA, Y. MATSUDAIRA, and Y. NISHIZUKA. 1983. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes. Cancer Res. 43: 4768.
4. RICHTERS, S., and C. L. KASPERSKY. 1975. Surface immunoglobulin positive lymphocytes in human breast cancer tissues and homolateral axillary lymph nodes. Cancer 35: 129.
5. TSAKRAKLIDES, E., V. TSAKRAKLIDES, H. ASHIKARI, P. P. ROSEN, F. P. SEGAL, G. F. ROBBINS, and R. A. GOOD. 1975. In vitro studies of axillary lymph nodes cells in patients with breast cancer. J. Natl. Cancer Inst. 54: 549.
6. EREMIN, O., P. ROBERTS, D. PLUMB, and J. P. STEPHENS. 1980. Human regional tumor lymph nodes: Alterations on micro-architecture and lymphocyte subpopulations. Br. J. Cancer 41: 62.
7. MOSMANN, T. R., and R. L. COFFMAN. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145.
8. COFFMAN, R. L., B. SEYMOUR, D. LEBMAN, D. HIRAKI, J. CHRISTIANSEN, B. SHRADER, H. CHERWINSKI, H. SAVELKOUL, F. FINKELMAN, M. BOND, and T. R. MOSMANN. 1988. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102:5.
9. BOOM, W. H., D. LIANO, and A. K. ABBAS. 1988. Heterogeneity of helper/inducer T lymphocytes. II. Effect of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes. J. Exp. Med. 167: 1350.
10. KILLAR, L., G. MACDONALD, J. WEST, A. WOODS, and K. BOTTOMLY. 1987. Cloned, Ia-restricted T cells that do not produce interleukin 4(IL-4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. J. Immunol. 138: 1674.
11. ROCK, K. L., B. BENACERRAF, and A. K. ABBAS. 1984. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160: 1102.
12. MALYNN, B. A., D. T. ROMEO, and H. H. WORTIS. 1985. Antigen specific B cells efficiently present low doses of antigen for induction of T cell proliferation. J. Immunol. 135: 980.
13. CLARK, E. A., and J. A. LEDBETTER. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens. Proc. Natl. Acad. Sci. USA 83: 4494.
14. ARMITAGE, R. J., W. C. FANSLOW, L. STROCKBINE, and M. K. SPRIGGS. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357: 80.
15. OLD, L. J., E. A. BOYSE, D. A. CLARKE, and E. A. CARSWELL. 1962. Antigenic properties of chemically induced tumors. Ann. NY Acad. Sci. 101: 80.
16. MATSUMOTO, T., K. HIMENO, and M. MITANI, 1986. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells. J. Clin. Lab. Immunol. 19: 83.
17. CZERKINSKY, C., L. NILSSON, H. NYGREN, Ö. OUCHTERLONY, and A. TARKOWSKI. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65: 109.
18. CZERKINSKY, C., G. ANDERSSON, H. EKRE, L. NILSSON, L. KLARESKOG, and Ö. OUCHTERLONY. 1988. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 110: 29.
19. ITOH, M., C. HIRAMINE, M. KOSETO, and K. HOJO. 1989. Enzyme-linked immunosorbent assay (ELISA) for antisperm antibodies in mice with testicular autoimmunity. Am. J. reprod. Immunol. 21:9.
20. CHERWINSKI, H. M., J. H. SCHUMACHER, K. D. BROWN, and T. R. MOSMANN. 1987. Two types of mouse helper T cell clones. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays and monoclonal antibodies. J. Exp. Med. 166: 1229.
21. WINN, H. J. 1961. Immune mechanism in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homograft. J. Immunol. 86: 228.
22. ULLICH, S. J., E. A. ROBINSON, L. W. LAW, M. WILLINGHAM, and E. APPELLA. 1986. A mice tumor-specific transplantation antigen is a heat shock-related protein. Proc. Natl. Acad. Sci. USA 83: 3121.
23. LI, Z., and P. K. SRIVASTAVA. 1993. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J. 12: 3143.
24. UDONO, H., and P. K. SRIVASTAVA. 1994. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152: 5398.
25. SHIMIZU, J., J. Zou, K. IKEGAME, T. KATAGIRI, H. FUJIWARA, and T. HAMAOKA. 1991. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. J. Immunol, 146: 1708.
26. MITANI, M., K. MORI, K. HIMENO, and K. NOMOTO. 1989. Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic marine tumor: Comparison between neonatally thymectomized mice and congenitally athymic nude mice. J. Immunol. 142: 2148.
27. + T cells show antitumor activity against syngeneic fibrosarcoma. Cancer Res. 53: 106.
28. TADA, T., S. OHZEKI, K. UTSUMI, H. TAKIUCHI, M. MURAMATSU, X. LI, J. SHIMIZU, H. FUJIWARA, and T. HAMAOKA. 1991. Transforming growth factor-β-induced inhibition of T cell function: Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol. 146: 1077.
29. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547.
30. TAYLOR-ROBINSON, A. W., R. S. PHILLIPS, A. SEVERN, S. MONCADA, and F. Y. LIEW, 1993. The role of Th1 and Th2 cells in a rodent Malaria infection. Science 260: 1931.
31. + T cells as Th1 cells based on lymphokine secretion and functional properties. J. Immunol. 144: 4898.
32. + effector T cells. J. Exp. Med. 159: 1295.
33. SCHULTZ, K. R., J. P. KLARNET, R. KLARNET, R. S. GIENI, K. T. HAYGLASS, and P. D. GREENBERG. 1990. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia. Science 921: 249.